We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CBK:XETRCommerzbank AG Analysis

Data as of 2026-05-25 - not real-time

$28.69

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Commercial Bancgroup (CBK) is trading just above its 20‑day SMA while the 20‑day SMA sits above the 50‑day SMA, indicating a short‑term bullish bias. The 200‑day SMA remains lower, supporting a longer‑term uptrend. RSI hovers in the mid‑50s, suggesting neither overbought nor oversold conditions. MACD shows a bearish histogram and the signal line is above the MACD line, warning of potential near‑term weakness. Volume has been increasing, adding credibility to the price movement.
Fundamentals reveal a low trailing PE of around ten versus an industry average of over sixteen, pointing to relative cheapness. The DCF fair value exceeds the current price by roughly eighteen percent, implying upside potential. Operating margins are robust and the payout ratio is under four percent, making the 0.7% dividend highly sustainable. The balance sheet shows ample cash relative to debt and a beta well below one, indicating limited market sensitivity. However, regional banks face medium regulatory and sector risks that could temper gains. Overall, the stock appears undervalued with a blend of value and modest growth characteristics.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • 20‑day SMA above 50‑day SMA indicating bullish bias
  • MACD bearish histogram suggesting near‑term weakness
  • Increasing volume supporting price movement

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF valuation indicates ~18% upside
  • Low PE relative to industry peers
  • Strong operating margins and cash generation

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustainable dividend with low payout ratio
  • Low beta and solid balance sheet
  • Blend of value pricing and modest growth prospects

Key Metrics & Analysis

Financial Health

Revenue Growth5.30%
Profit Margin41.77%
P/E Ratio10.3
ROE14.64%
ROA1.65%
P/B Ratio1.3
Op. Cash Flow$38.4M
Industry P/E16.8

Technical Analysis

TrendBullish
RSI54.2
Support$27.25
Resistance$29.75
MA 20$28.68
MA 50$27.61
MA 200$25.85
MACDBearish
VolumeIncreasing
Fear & Greed Index91.8

Valuation

Fair Value$35.68
Target Price$34.00
Upside/Downside18.51%
GradeUndervalued
TypeBlend
Dividend Yield0.70%

Risk Assessment

Beta0.51
Volatility21.68%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.